Genentech

TNKASE

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Genentech

Tnkase HCPCS:

J3101

HCPCS Code Descriptor:

Injection, tenecteplase, 1 mg

Category:

J Code

Tnkase NDCs:

50242-0120-47

Primary Type:

Thrombolytic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Tnkase CPT Codes:

Potential CPT administration codes for Tnkase can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Tnkase:

TNKASE is a Thrombolytic drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J3101 is aligned to the drug TNKASE.

ACCESS PRICING AND MORE BY REGISTERING

J3101 Added Date:

January 1, 2009

J3101 Effective Date:

January 1, 2009

J3101 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Tnkase billing and coding information.
Tnkase patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
TNKASE prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for TNKASE. Please check back in a few weeks.